Testing CBD and naltrexone for alcohol craving
Treatments studied
Part of Mental health clinical trials.
This trial is testing if taking cannabidiol (CBD) plus naltrexone can reduce alcohol craving in people with alcohol dependence. Naltrexone is already used to help with alcohol cravings, and CBD may add extra benefit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You have a diagnosis of alcohol dependence and often experience alcohol cravings
- You are not currently taking certain medications (the study team will check this)
- You can use effective birth control if there is any chance of pregnancy
- You do not have a severe liver problem, epilepsy, or a serious mental health condition like bipolar disorder or psychosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 study tests whether naltrexone injections can help people with alcohol use disorder (AUD) reduce or stop heavy drinking. You may get two injections over 8 weeks, and you can join if you meet specific drinking pattern and eligibility rules.
This study tests whether a medication called cannabidiol (CBD) can help reduce cravings for alcohol. Over several weeks, you will take the study pill and attend lab sessions where you can choose to drink alcohol in a safe setting.
This study tests whether cannabidiol (CBD) can help reduce alcohol withdrawal symptoms and cravings when added to usual care. If you are a heavy drinker with alcohol use disorder and have experienced withdrawal, this trial may offer a new approach to manage cravings and safely quit drinking.
This trial tests whether cannabidiol (CBD) can help people cut down or quit drinking alcohol. It enrolls adults diagnosed with alcohol use disorder and wanting to reduce drinking, while checking for safety and other mental health or drug use factors.
This trial tests whether cannabidiol (CBD) given during an inpatient alcohol detox helps people stay off alcohol afterward. You would be compared with standard care to see if CBD improves recovery during and after withdrawal.
This trial tests two medicines — semaglutide and naltrexone — taken together to help reduce alcohol cravings and drinking. It aims to see if this combination is more effective than standard treatment for alcohol use disorder.
Hear when a new Alcohol Addiction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.